Triostat

Triostat is a brand name of liothyronine, approved by the FDA in the following formulation(s):

TRIOSTAT (liothyronine sodium - injectable; injection)

• 
  Manufacturer: JHP PHARMS
  
  Approval date: December 31, 1991
  
  Strength(s): EQ 0.01MG BASE/ML ^[RLD][AP]

Has a generic version of Triostat been approved?

Yes. The following products are equivalent to Triostat:

liothyronine sodium injectable; injection

• 
  Manufacturer: X GEN PHARMS
  
  Approval date: August 17, 2005
  
  Strength(s): EQ 0.01MG BASE/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Triostat. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Triostat.

See also...

• Triostat Consumer Information (Wolters Kluwer)
• Triostat Advanced Consumer Information (Micromedex)
• Liothyronine Consumer Information (Wolters Kluwer)
• Liothyronine Tablets Consumer Information (Wolters Kluwer)
• Liothyronine Consumer Information (Cerner Multum)
• Liothyronine Advanced Consumer Information (Micromedex)
• Liothyronine Intravenous Advanced Consumer Information (Micromedex)
• Liothyronine Sodium AHFS DI Monographs (ASHP)